As a heterogeneous disease, breast cancer has been classified into several molecular subtypes2, including HER2-positive breast cancer which is defined as the subtype with amplified and/or overexpressed HER2 (or erbB2) gene3. This evidence concerns the gene ERBB2 and breast cancer.